Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate MetabolismSummary
A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease (NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and diabetes. The spectrum of NAFLD ranges from simple hepatic fat accumulation to a more severe disease termed nonalcoholic steato...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019-01-01
|
| Col·lecció: | Cellular and Molecular Gastroenterology and Hepatology |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2352345X18301462 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|